BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8863098)

  • 1. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML; Grobbee DE
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades.
    Taylor R; Dobson A; Mirzaei M
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):760-8. PubMed ID: 17001216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drop in cardiovascular and coronary mortality in Lombardia, 1969-1987. Evaluation of reliability of the estimates and possible explaining hypothesis].
    Cesana G; Ferrario M; Sega R; Bravi C; Gussoni MT; De Vito G; Valagussa F
    G Ital Cardiol; 1992 Mar; 22(3):293-305. PubMed ID: 1426772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand.
    Tobias M; Taylor R; Yeh LC; Huang K; Mann S; Sharpe N
    Aust N Z J Public Health; 2008 Apr; 32(2):117-25. PubMed ID: 18412680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decrease in coronary heart disease mortality in 1974-1992 largely explainable by changes in cholesterol and smoking risk factors].
    Oei LT; Erkelens DW
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2309-14. PubMed ID: 7501064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: the Minnesota Heart Survey.
    Burke GL; Sprafka JM; Folsom AR; Luepker RV; Norsted SW; Blackburn H
    Int J Epidemiol; 1989; 18(3 Suppl 1):S73-81. PubMed ID: 2807710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health care quality: medication and prevention in patients with and without coronary heart disease].
    Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
    Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II).
    Mensah GA; Brown DW; Croft JB; Greenlund KJ
    Am J Prev Med; 2005 Dec; 29(5 Suppl 1):68-74. PubMed ID: 16389129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.